Objectives To determine the procedural safety, safety, and efficacy of left atrial appendage
(LAA) occlusion in octogenarians. Background Elderly patients with atrial fibrillation (AF) …

Introduction and objectives Elderly patients with atrial fibrillation are at greater risk of both
cardioembolic events and major bleeding than younger patients. Left atrial appendage …

Background: Percutaneous left atrial appendage occlusion (LAAO) therapy using the
WATCHMAN system has been introduced to prevent thrombosis and minimize the use of …

Left atrial appendage occlusion (LAAO) is emerging as a promising alternative to oral
anticoagulation. Because aged patients present a greater risk of not only cardioembolic …

Background Data on the safety and efficacy of left atrial appendage occlusion (LAAO) in
elderly patients are limited. Objectives This study aimed to compare the outcomes of LAAO …

The mean age in clinical trials of percutaneous left atrial appendage occlusion (LAAO) has
been< 75 years. We aimed to better understand the safety of LAAO in older patients …

Objectives To compare indications and clinical outcomes of two contemporary left atrial
appendage (LAA) percutaneous closure systems in a “real‐world” population. Background …

Background Catheter ablation (CA) combined with left atrial appendage occlusion (LAAO) is
a feasible approach for atrial fibrillation (AF) patients. Its role in octogenarians with AF is …

Objectives: The aim of this study was to evaluate long-term outcomes in patients with atrial
fibrillation undergoing percutaneous left atrial appendage (LAA) closure with the Watchman …

Percutaneous left atrial appendage closure (LAAC) may decrease risks of stroke and
bleeding in elderly patients with non-valvular atrial fibrillation (NVAF), but it is still lacking of …